(Q47582474)

4 February 2018

title

Dose-dependent antihypertensive efficacy and tolerability of perindopril in a large, observational, 12-week, general practice-based study (English)

1 reference

4 February 2018

1 reference

George Tsoukas

1

1 reference

4 February 2018

Sanjiv Anand

series ordinal

2

1 reference

4 February 2018

Kwang Yang

series ordinal

3

1 reference

4 February 2018

CONFIDENCE Investigators

series ordinal

4

1 reference

4 February 2018

publication date

1 January 2011

1 reference

4 February 2018

American journal of cardiovascular drugs

published in

1 reference

4 February 2018

volume

11

1 reference

4 February 2018

issue

1

1 reference

4 February 2018

page(s)

45-55

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.2165/11587000-000000000-00000

exact match

0 references

cites work

Global burden of hypertension: analysis of worldwide data

1 reference

https://api.crossref.org/works/10.2165%2F11587000-000000000-00000

Hypertension treatment and control in five European countries, Canada, and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587000-000000000-00000

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587000-000000000-00000

Highlights and summary of the 2006 Canadian Hypertension Education Program recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587000-000000000-00000

Clinical experience with perindopril in patients nonresponsive to previous antihypertensive therapy: a large US community trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587000-000000000-00000

Antihypertensive utility of perindopril in a large, general practice-based clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587000-000000000-00000

Perindopril for control of blood pressure in patients with hypertension and other cardiovascular risk factors: an open-label, observational, multicentre, general practice-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587000-000000000-00000

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587000-000000000-00000

Treatment of hypertension in patients 80 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587000-000000000-00000

Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians' Desk Reference

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587000-000000000-00000

Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587000-000000000-00000

Antihypertensive efficacy of perindopril 5-10 mg/day in primary health care: an open-label, prospective, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587000-000000000-00000

Perindopril arginine: benefits of a new salt of the ACE inhibitor perindopril

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587000-000000000-00000

Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587000-000000000-00000

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587000-000000000-00000

10.2165/11587000-000000000-00000

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

Dimensions Publication ID

1010867245

0 references

1 reference

4 February 2018